Adsorbent Pharmaceutical Composition for Respiratory Damage
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for respiratory damage caused by pathogens, bacteria, toxins, and inflammatory responses, such as cytokine storms, are inadequate in controlling inflammation and removing harmful substances from the lungs, leading to high mortality rates and immune system suppression.
Innovation Solution
A pharmaceutical composition comprising an adsorbent medicament, such as carbon materials or positively/negatively charged compounds, combined with a water-containing carrier, designed to adsorb proinflammatory cytokines, chemokines, bacteria, viruses, and toxins, thereby mitigating inflammation and cytokine storms without suppressing the immune system.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If steroid treatment is used to curb immune response and reduce inflammation, then inflammation is reduced, but immune system function is suppressed and mortality rate increases
Solution Approach 1:
The invention separates the treatment of inflammation from immune suppression by using adsorbent materials to selectively remove proinflammatory cytokines and harmful substances from the lungs, rather than using steroids that broadly suppress the entire immune system. This segmentation allows inflammation control while preserving immune function.
Solution Approach 2:
The adsorbent medicament acts as an intermediary substance that binds to and removes harmful factors (proinflammatory cytokines, toxins, bacteria, viruses) from the lung environment, mediating between the immune response and the inflammatory damage without suppressing the immune system's overall function.
2Object-generated harmful factors
If normal saline irrigation is used to wash away harmful substances from lungs, then some substances are removed, but adhered toxins and cytokines cannot be effectively eliminated
Solution Approach 1:
The invention employs adsorbent materials with porous structures (such as activated carbon, molecular sieves, or other porous adsorbents) that can effectively adsorb and remove harmful substances including adhered toxins, proinflammatory cytokines, bacteria, and viruses from the lung tissue and fluids, overcoming the limitations of normal saline irrigation.
Solution Approach 2:
The pharmaceutical composition uses composite materials combining adsorbent medicaments with appropriate carriers or vehicles, creating a formulation that enhances the removal efficiency of diverse harmful substances while being compatible with the lung environment and effective against various pathogens and toxins.
3Reliability
If supportive therapy with oxygen supply is used to help patients survive, then patients can endure the critical stage, but no active treatment controls the cytokine storm
Solution Approach 1:
The invention extracts and removes the harmful proinflammatory cytokines and other harmful substances from the lung environment using adsorbent materials, directly addressing the cytokine storm mechanism rather than merely providing supportive care. This extraction approach actively controls the inflammatory process while maintaining patient survival.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition effectively reduces pulmonary edema, inflammation, and cytokine storm severity, preserving immune function and lowering mortality rates by adsorbing harmful substances from the lungs, thus improving respiratory system damage across various disease progressions.
Implementation Method 1
an adsorbent medicament, such as carbon materials or positively/negatively charged compounds... designed to adsorb proinflammatory cytokines, chemokines, bacteria, viruses, and toxins
Data Source
AI summary
The present invention provides a pharmaceutical composition for improving respiratory damage. The pharmaceutical composition includes an adsorbent medicament and a water-containing carrier, wherein said adsorbent medicament comprises a carbon material, a molecular sieve or a positively and negatively charged compound. The present invention also provides use for manufacturing pharmaceutical composition for improving respiratory damage.